Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 332
Immune Disorders Drugs 209
Biopharmaceuticals 178
Musculoskeletal Disorders Drugs 126
Genomics 114
Cardiovascular Drugs 106
Biotechnology 83
Pharmaceuticals 81
Drug Discovery 78
Endocrine and Metabolic Disorders Drugs 77
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 63
Leukemia Drugs 62
Hematological Drugs 60
Oncology 52
Clinical Trials 51
Dermatological Drugs 50
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 40
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 29
Brain Cancer Drugs 28
Proteomics 27
Enzymes 27
Gastrointestinal Drugs 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Infectious Diseases Drugs 23
Lymphoma Drugs 22
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Dermatology 18
Optical 17
Therapeutic Area 16
Healthcare Services 15
Respiratory Drugs 15
Urology and Nephrology 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Gastroenterology 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Company Reports 4
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,085 Results (Page 23 of 105)
- Relevance
  Sort by

Darbepoetin Alfa Market - Global Forecast 2026-2032

 Report
January 2026
184 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Kidney Transplant Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Leukemia Therapeutics Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3815EUR$4,150USD£3,243GBP

Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3815EUR$4,150USD£3,243GBP

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1838EUR$2,000USD£1,563GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Monoclonal Gammopathy of Undetermined Significance Treatment Market - Global Forecast 2026-2032

 Report
September 2026
193 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Anti-anemia Drugs Market - Global Forecast 2026-2032

 Report
September 2026
189 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Ankylosing Spondylitis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

US Healthcare Outlook Report, 2025

 Report
April 2025
60 Pages
United States

From

€1834EUR$1,995USD£1,559GBP

Myasthenia Gravis Treatment Market: Forecast and Trends

 Report
November 2023
120 Pages
Global

From

€4274EUR$4,650USD£3,634GBP

Systemic Lupus Erythematosus Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Epoetin-alfa Erythropoietin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
86 Pages
Global

From

€3500EUR$4,079USD£3,080GBP

Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

 Report
March 2023
350 Pages
Europe

From

€3676EUR$3,999USD£3,125GBP

Sickle Cell Treatment Market - Global Forecast 2026-2032

 Report
September 2026
190 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Injection Devices for Subcutaneous Self-administration to 2028

 Report
April 2022
250 Pages
Global

From

€6297EUR$6,850USD£5,354GBP

Acquired Orphan Blood Diseases Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
182 Pages
Global

From

€4137EUR$4,500USD£3,517GBP

Neutropenia Treatment Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Heart Failure Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
180 Pages
Global

From

€4137EUR$4,500USD£3,517GBP

Darbepoetin Alfa (Aranesp) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
162 Pages
Global

From

€1838EUR$2,000USD£1,563GBP

2,085 Results (Page 23 of 105)
- 1
- 21
- 22
- 23
- 24
- 25

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.